Each new pharmaceutical is a life-changing technological wonder.
The Sternfels Prize was created to reduce the risk associated with the
real-world use of pharmaceuticals. The purpose of the prize is to incentivize pharmacologists,
pharmacists, medical practitioners, academics, and students to think about ways to reduce the real
world risks patients face from polypharmacy, interacting co-morbidities, and genetic variations.
The prize is awarded to the most novel, important, and testable idea to reduce life threatening drug-drug, drug-disease, or
pharmacogenomic interactions. All submissions must be the applicant’s own work and not already be
adequately addressed on an existing drug label or in a scholarly work. The winning submission will receive $35,000 (USD).
New this Year
Now open worldwide!
The winner will receive a $35,000 cash award for having the best idea.
All submissions are due by January 31, 2018. If you would like feedback on your proposal and a chance to resubmit, please submit your application by December 15, 2017.
A panel of 5 renowned judges will determine the winner based on the Prize's stated criteria.
*Qualifying submissions are proposals for novel, unpublished ideas as determined by the Sternfels staff